First stroke patient treated with Rapid Medical’s Tigertriever

660

Rapid Medical’s Tigertriever has been used to treat its first patient. Using Rapid Medical’s proprietary technology, this stent retriever is designed to be fully visible and controllable. The device can be adjusted by physicians to fit the dimensions of blood vessels causing acute ischaemic stroke, and is the first of its kind, according to the company. 

“I am very pleased with the results and performance of the device,” says René Chapot, head of the Neuroradiology Department at Alfried Krupp Hospital in Essen, Germany. “The Tigertriever’s unique braiding and adjustability allowed me to safely secure the blood clot during its retrieval and achieve complete recanalisation in one attempt. The Tigertriever has vast clinical potential and I am very happy to be the first physician using this breakthrough device.”

The Tigertriever uses Rapid Medical’s proprietary technology platform, which is based on seven years’ experience in controllable and visible advanced braided stent design. It is intended to accomplish both continuous adjustability and high radial force.

Rapid Medical plans to launch the Tigertriever in Europe during Q2 2016.